Skip to main content
. 2019 Jun 6;37(21):1819–1827. doi: 10.1200/JCO.19.00014

FIG 3.

FIG 3.

Cumulative incidence of late relapse for (A) all histologies combined, (B) diffuse large B-cell lymphoma (DLBCL), and (C) indolent lymphoma in patients with germinal center B-cell–like (GBC) DLBCL and in patients with non-GCB DLBCL. EFS24, event-free survival at 24 months.